Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Patients were treated with MIPLYFFA in a 48-month open-label extension (OLE) study following the Phase 2/3, randomized, double-blind, placebo-controlled pivotal trial. The OLE data demonstrate that ...

Northwestern Engineering faculty and students participated in the annual forum for advances in theory, empirics, and ...

The House is expected to approve President Donald Trump’s request to claw back about $9 billion in already appropriated ...